ARCHIVES

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

This article is from The Cancer Letter archive.

Vol. 39 No. 28 | July 12, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA

October 15, 1982

In Brief: General Motors Cancer Research Foundation Prizewinners: Brock, Li, Fraumeni, Harlow

June 16, 1995

NTP Staff Members In Bethesda Told They Must Move

December 16, 1983

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

October 31, 2014

Bennett, CCIRC Members Disagree On state Of Groups, Simons New Chairman

June 27, 1980

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013